Africa has made significant progress against HIV over the past decade, reducing new infections by 43% and nearly halving AIDS-related deaths. However, the continent is unlikely to end AIDS as a public health threat by 2030 with many countries falling behind key elimination milestones and COVID-19 aggravating challenges, an analysis by World Health Organization (WHO) finds.
To achieve the 2030 global development goal of ending AIDS, countries should ensure that by 2025 95% of people living with HIV know their status (target 1), 95% of those who know their status are on treatment (target 2) and 95% of those receiving treatment have their viral load suppressed (target 3). The Fast-Track strategy to end AIDS was initiated in December 2015 by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and then in December 2020, the new 95-95-95 five-year plan replaced the previous targets.
WHO is tracking progress toward the 95-95-95 targets with a scorecard which was released today at the International Conference on AIDS and Sexually Transmitted Infections in Africa gathering in Durban, South Africa. The scorecard finds that in December 2021, countries in the African region reported 87% of people living with HIV know their status, of those 77% are on treatment and 68% have low viral load. So far only nine countries—Botswana, Cabo Verde, Kenya, Lesotho, Malawi, Nigeria, Rwanda, Uganda and Zimbabwe—are on track to reach the 95-95-95 targets by 2025.
“This scorecard is a wake-up call for African governments to stay focused on ending AIDS,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “COVID-19 has made the fight against HIV all the more challenging, but one virus must not win out over another. We must tackle COVID-19 and HIV in parallel.”
The scorecard finds that no country has met all three 95-95-95 targets, but Eswatini has exceeded the first two and is within sight of the third, with 93% of people on treatment having their viral load suppressed.
Three countries—Cabo Verde, Djibouti, and Kenya—have met the first target. Cabo Verde has also reached the second. Eight countries are close to meeting the first target and three— Rwanda, Uganda and Zimbabwe—are nearing the second objective, but inadequate access to HIV testing and treatment for key populations is hampering progress. Community-based services and stigma-free health facilities can help ensure men who have sex with men, injecting drug users, sex workers and other key populations get the health care they need.
Target three has made the least progress, with 48% of countries reporting no data. This is due to the scarcity of viral load testing centres in many countries, especially in rural areas, which has worsened during the COVID-19 pandemic as testing centres have turned to focus on the new virus
“Africa has come so far, and we know how to end AIDS. But unless governments make a fresh push, increasing resources and commitment to strengthening their fragile health systems we will not reach the last mile,” Dr Moeti said.
Key steps to accelerate the momentum against the disease include improving access to HIV treatment and care, notably by decentralizing services to the grassroots and eliminating user fees for key services, increasing domestic funding by governments for HIV programmes as well as boosting the fight against stigma and discrimination so that those who need care have no fear seeking it.
Distributed by APO Group on behalf of WHO Regional Office for Africa.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
